| Insights into structures of imidazo oxazines as potent polyketide synthase XIII inhibitors using molecular modeling techniques B Shanthakumar, MK Kathiravan Journal of receptor and signal transduction research 40 (4), 313-323, 2020 | 16 | 2020 |
| An overview of mechanism and chemical inhibitors of shikimate kinase BK Chagaleti, MBR Reddy, V Saravanan, P Senthil Kumar, ... Journal of Biomolecular Structure and Dynamics 41 (23), 14582-14598, 2023 | 11 | 2023 |
| Targeting cyclin-dependent kinase 2 CDK2: Insights from Molecular Docking and Dynamics Simulation-A systematic computational approach to discover novel cancer therapeutics BK Chagaleti, BS Kumar, R Rajagopal, A Alfarhan, J Arockiaraj, ... Computational Biology and Chemistry, 108134, 2024 | 7 | 2024 |
| Imidazooxazine moiety as polyketide synthase 13 inhibitors targeting tuberculosis B Shanthakumar, P Gopinath, BK Chagaleti, V Saravanan, ... Journal of King Saud University-Science 36 (6), 103220, 2024 | 5 | 2024 |
| In silico Design and Synthesis of Some New Imidazole Derivatives for Tuberculosis A Jena, C Prakashraj, BK Chagaleti, MK Kathiravan, BS Kumar Indian J Heterocycl Chem 33, 2023 | 5 | 2023 |
| Design synthesis and biological evaluation of thiophene 2-pentafluoro benzamide derivatives as antitubercular agent B Shanthakumar, V Saravanan, BK Chagaleti, MK Kathiravan J Med Pharm Allied Sci 12, 2023 | 5 | 2023 |
| 2, 4-Substituted Oxazolones: Antioxidant Potential Exploration A Thanvi, BK Chagaleti, R Srimathi, MK Kathiravan, B Shanthakumar Journal of Young Pharmacists 16 (2), 244-251, 2024 | 1 | 2024 |
| Exploring the Impact of Artificial Intelligence and Machine Learning in New Drug Discovery T Sundarrajan, D Priya, MK Kathiravan, V Velmurugan, GV Anjana, ... BP International (a part of SCIENCEDOMAIN International), 2023 | | 2023 |
